BNP Paribas Financial Markets
PROK icon

BNP Paribas Financial Markets’s ProKidney PROK Stock Holding History

BNP Paribas Financial Markets’s Portfolio PROK Stock Details PROK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$7.38K Buy
4,121
+3,250
+373% +$6.89K ﹤0.01% 5266
2025
Q4 		$1.95K Sell
871
-923
-51% -$2.43K ﹤0.01% 5350
2025
Q3 		$4.34K Sell
1,794
-12,576
-88% -$33.5K ﹤0.01% 5106
2025
Q2 		$8.51K Sell
14,370
-81,522
-85% -$63.5K ﹤0.01% 4876
2025
Q1 		$84K Buy
95,892
+30,556
+47% +$42.4K ﹤0.01% 4095
2024
Q4 		$110K Buy
+65,336
New +$118K ﹤0.01% 4131

Other funds holding PROK

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
AGP
Artia Global Partners Miami, Florida $499M AUM 186.05% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

BNP Paribas Financial Markets's PROK Position: Q1 2026 in Review

BNP Paribas Financial Markets increased its ProKidney (PROK) stake by 373% in Q1 2026, buying an estimated $6.89K and bringing the position to 4,121 shares worth $7.38K. The position accounts for ﹤0.01% of the portfolio, ranked #5266.

BNP Paribas Financial Markets first reported a position in PROK in Q4 2024 and has held it in 6 quarters since. The position peaked at $110K in Q4 2024. 71 funds tracked by Wall St. Rank hold PROK as of Q1 2026.

  • BNP Paribas Financial Markets held 4,121 shares of ProKidney worth $7.38K as of Q1 2026.
  • BNP Paribas Financial Markets bought 3,250 ProKidney shares in Q1 2026, an estimated $6.89K.
  • ProKidney made up ﹤0.01% of BNP Paribas Financial Markets's portfolio in Q1 2026, its #5266 holding.
  • BNP Paribas Financial Markets first reported a position in ProKidney in Q4 2024 and has held it in 6 quarters since.
  • BNP Paribas Financial Markets's ProKidney position peaked at $110K in Q4 2024.
  • 71 funds tracked by Wall St. Rank held ProKidney as of Q1 2026.

Based on BNP Paribas Financial Markets's 13F filing for Q1 2026, filed 12 May 2026.